**To:** Alder Loom Management **From:** Counsel, Merger & Acquisitions **Date:** October 26, 2023 **Subject:** Merger Screening Analysis & Filing Recommendation: Alder/Prism Acquisition ### Executive Summary Based on the verified data available today, a premerger filing is likely required in the **Medical Conductive Mesh** market. While the Industrial Conductive Yarn market appears to fall below the statutory thresholds, the Medical Market currently shows a combined share of 30%, exceeding the 25% trigger under Corda law. Management’s proposal to assume that "imports probably push us below 25 percent" violates Corda Rule 7. Counsel cannot assume an unverified market input in the direction preferred by the client. However, given the ability to verify import revenue within ten days and a closing date of 35 days, we recommend **waiting for the verification work before filing or closing**. --- ### 1. Industrial Conductive Yarn Analysis This market is fully defined with verified market shares summing to 100%. * **Combined Share:** * Alder Loom: 12% * Prism Thread: 8% * **Total:** 20% (Does not meet the $\ge$ 25% threshold). * **Herfindahl-Hirschman Index (HHI) Calculation:** * **Premerger HHI:** Sum of squared shares. $$12^2 + 8^2 + 25^2 + 20^2 + 15^2 + 10^2 + 10^2$$ $$= 144 + 64 + 625 + 400 + 225 + 100 + 100 = \mathbf{1,658}$$ * **Postmerger HHI Increase ($\Delta$HHI):** Twice the product of merging shares. $$2 \times (12 \times 8) = 2 \times 96 = \mathbf{192 \text{ points}}$$ * **Postmerger HHI:** $$1,658 + 192 = \mathbf{1,850}$$ * **Filing Trigger & Structural Presumption:** * **Share Test:** Failed (20% < 25%). * **HHI Test:** Requires Post-merger HHI > 1,800 **AND** $\Delta$HHI > 200. * Post-merger HHI (1,850) > 1,800: **Met.** * $\Delta$HHI (192) > 200: **Not Met.** * **Conclusion:** Because the "and" condition in Rule 1(b) is not satisfied, **no filing is triggered** by the Industrial Conductive Yarn market. There is also no structural presumption of harm. --- ### 2. Medical Conductive Mesh Analysis This market has verified domestic revenue ($80 million) but unverified imports ($0–$30 million). Alder and Prism hold $24 million of verified combined revenue. #### A. Combined-Share Formula Under Rule 3, claimed imports are included only if verified. The combined share is calculated as: $$ \text{Combined Share} = \frac{\text{Alder Revenue + Prism Revenue}}{\text{Verified Domestic Revenue + Verified Import Revenue}} $$ $$ \text{Combined Share} = \frac{\$24\text{ million}}{\$80\text{ million} + I} $$ #### B. Import-Revenue Threshold for Filing Trigger Rule 1 requires filing if the combined share is at least 25%. To avoid this specific trigger, imports ($I$) must increase the market denominator sufficiently to drop the share below 0.25. $$ \frac{24}{80 + I} < 0.25 $$ $$ 24 < 0.25(80 + I) $$ $$ 24 < 20 + 0.25I $$ $$ 4 < 0.25I $$ $$ \mathbf{16\text{ million}} < I $$ **Result:** If verified import revenue exceeds **$16 million**, the combined share falls below 25%. If imports are $16 million or less, the share remains at or above 25%, triggering a mandatory filing. Based on current *verified* facts ($0 imports), the share is 30%, which triggers a filing requirement. #### C. Why Medical-Mesh HHI Cannot Be Calculated Reliably HHI requires the squared shares of *all* significant competitors in the market. While we know the total revenue for "Other verified sellers" ($56 million) and Alder/Prism ($24 million), we do not know: 1. The exact total volume of qualifying imports (currently estimated $0–$30M). 2. The **seller-by-seller breakdown** of that import revenue. As stated in the facts, "No verified seller-by-seller import shares are available." Without knowing the individual market shares of the import competitors, we cannot calculate the sum of squared shares for the postmerger state. Consequently, we cannot determine if the HHI triggers (Post > 1,800 and $\Delta$HHI > 200) even if total revenue is known. --- ### 3. Data Verification Requirements To comply with Rule 7, counsel must obtain "known, obtainable market input[s]" rather than assuming them in the client's favor. * **Specific Data Needed:** We require a specialist report verifying qualifying import revenue delivered into Corda during the measurement year. * **Availability:** A specialist can verify this revenue within **ten days** using customer and importer records. * **Limitation:** While this determines total market size (for Share calculation), it may not resolve the HHI uncertainty due to the lack of seller-level breakdowns for imports. However, resolving the total denominator is a necessary first step under Rule 7. --- ### 4. Filing and Gun-Jumping Consequences * **Gun-Jumping Penalty:** Under Rule 6, if a filing is required and not made prior to closing, each party faces a penalty of **$40,000 per day** from closing until compliance. * For Alder Loom alone: $40,000/day. * If closing occurs without clearance after verification confirms the trigger is met, cumulative fines could easily exceed $1 million within a month of discovery, alongside regulatory injunctions or divestiture orders. * **Filing Implication:** Filing does not concede illegality (Rule 8). It merely acknowledges the screening requirement. The parties retain the right to present efficiencies or entry evidence post-filing. --- ### 5. Recommendation **Recommendation: Do not close for at least 10 days. Engage specialist immediately to verify imports.** We cannot proceed with closing ("proceed without filing") based on management's assumption of high imports, as this violates **Rule 7**. We also should not "file now" blindly, as the transaction may not require it if verified imports exceed $16 million, which would unnecessarily delay the deal. **Action Plan:** 1. **Immediate Action (Day 0):** Engage the specialist to verify qualifying import revenue ($80M vs $80M + I). Simultaneously, suspend the closing date to ensure compliance. 2. **Scenario A: Verified Imports > $16 million.** * Combined Share will be < 25%. The primary filing trigger (Share) is avoided. * While HHI remains uncalculated due to missing seller data, the risk of a structural presumption is significantly reduced given the lower combined share. Management may choose to proceed without filing or file conservatively depending on internal risk tolerance, though the legal obligation is weaker. 3. **Scenario B: Verified Imports $\le$ $16 million.** * Combined Share will be $\ge$ 25%. * **Action:** File immediately under Rule 1(a). This can still be done before the current 35-day close target. 4. **Closing Timeline:** Since we have 35 days to close and verification takes only 10 days, there is sufficient time to resolve this data gap without breaching commercial deadlines. **Conclusion:** Wait for the ten-day data work. Do not close until the import revenue figure is verified to ensure Rule 7 compliance and avoid potential $40,000/day penalties under Rule 6.